0001144204-12-067785.txt : 20121213 0001144204-12-067785.hdr.sgml : 20121213 20121213133535 ACCESSION NUMBER: 0001144204-12-067785 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121213 DATE AS OF CHANGE: 20121213 EFFECTIVENESS DATE: 20121213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Morria Biopharmaceuticals PLC CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-188250 FILM NUMBER: 121261676 BUSINESS ADDRESS: STREET 1: 53 DAVIES STREET CITY: LONDON STATE: X0 ZIP: W1K 5JH BUSINESS PHONE: 646-878-0804 MAIL ADDRESS: STREET 1: C/O MARK COHEN, CHAIRMAN, PEARL COHEN STREET 2: 1500 BROADWAY, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 D/A 1 primary_doc.xml X0706 D/A LIVE 0001541157 Morria Biopharmaceuticals PLC 53 DAVIES STREET LONDON X0 UNITED KINGDOM W1K 5JH +44-207-152-6341 UNITED KINGDOM None None Corporation true YUVAL COHEN 53 DAVIES STREET LONDON X0 UNITED KINGDOM W1K 5JH Executive Officer Director DOV ELEFANT 53 DAVIES STREET LONDON X0 UNITED KINGDOM W1K 5JH Executive Officer SAUL YEDGAR DEPARTMENT OF BIOCHEMISTRY HEBREW UNIVERSITY - HADASSAH MED SCHOOL JERUSALEM L3 ISRAEL 91120 Executive Officer Director MARK COHEN CHAIRMAN, PEARL COHEN ZEDEK LATZER, LLP 1500 BROADWAY, 12TH FLOOR NEW YORK NY NEW YORK 10036 Director JOHNSON LAU 701 ELLICOTT STREET BUFFALO NY NEW YORK 14203 Director GILEAD RADAY 255 KEFAR-URIA KEFAR-URIA L3 ISRAEL 76308 Director AMOS EIRAN 2 AVNER ST. HERZELIYA L3 ISRAEL 46662 Director ALAN HARRIS 190 E. 72ND STREET, 32C NEW YORK NY NEW YORK 10021 Executive Officer DAVID SIDRANSKY HA'ARI 39 REHOVOT L3 ISRAEL 7637239 Director Biotechnology No Revenues 06 true 0001144204-12-067596 2012-11-30 false true true true false 0 Garden State Securities, Inc. 10083 None None 328 NEWMAN SPRINGS ROAD RED BANK NJ NEW JERSEY 07701 CA CALIFORNIA GA GEORGIA IL ILLINOIS MN MINNESOTA MO MISSOURI NJ NEW JERSEY NY NEW YORK OH OHIO PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS UT UTAH false 1503000 1503000 0 false 20 350600 true 0 Garden State Securities, Inc. served as placement agent for the Issuer and received a warrant to purchase 90,180 shares at $2 per share, $25,000 as reimbursement of legal fees, and $145,200 in sales commissions. 0 false Morria Biopharmaceuticals PLC /s/ Dov Elefant Dov Elefant Chief Financial Officer 2012-12-13